Skip to main content

Legal & General Group Plc

Position in NBIX — Neurocrine Biosciences Inc

CIK 764068 London, X0

Position in NBIX

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$50,138,793
+$3,248,945 QoQ
Shares Held
380,589
+15.1% QoQ
Ownership
0.379%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 83.48428357099128.ToString("F0")% Shared 0.ToString("F0")% None 16.51571642900872.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Legal & General Group Plc holds $884,912,076 across 47 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (5.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NBIX
Neurocrine Biosciences Inc
This page
380,589 $50,138,793

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $50,138,793 380,589
2025-12-31 $46,889,848 330,606
2025-09-30 $56,175,863 400,170
2025-06-30 $50,203,853 399,426
2025-03-31 $42,351,725 382,927
2024-12-31 $47,186,684 345,690
2024-09-30 $45,003,202 390,585
2024-06-30 $55,412,036 402,499
2024-03-31 $55,528,797 402,616
2023-12-31 $58,172,961 441,507
2023-09-30 $50,416,650 448,148
2023-06-30 $43,164,127 457,732
2023-03-31 $49,994,379 493,918
2022-12-31 $58,671,554 491,222
2022-09-30 $52,790,405 497,038
2022-06-30 $49,394,090 506,710
2022-03-31 $44,384,156 473,431
2021-12-31 $38,086,064 447,177
2021-09-30 $43,171,104 450,121
2021-06-30 $43,647,630 448,496
2021-03-31 $39,442,751 405,581
2020-12-31 $32,463,531 338,691
2020-09-30 $35,404,092 368,179
2020-06-30 $46,053,170 377,485
2020-03-31 $24,450,806 282,505